Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis - Poll - MDSpire

Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis

  • By

  • Jingqiang Xie

  • Chunying Pu

  • Mingyue Sun

  • July 3, 2026

  • 0 min

Share

Original Source(s)

Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis

  • by Jingqiang Xie, Chunying Pu, Mingyue Sun

  • July 3, 2026

Related Content

Risk factors and mediating mechanisms of restless legs syndrome in patients undergoing maintenance hemodialysis: a longitudinal cohort study combined with Mendelian randomization analysis

The effect of peer support on fear of disease progression in patients with glioma: a protocol for systematic review and meta-analysis

Anxiety, depression and health-related quality of life in patients with thoracic aortic disease: a longitudinal study in a cardiothoracic outpatient clinic